Abstract
Annexin V recognizes apoptotic cells by specific molecular interaction with phosphatidyl serine, a lipid that is normally sequestered in the inner leaflet of the cell membrane, but is translocated to the outer leaflet in apoptotic cells, such as foam cells of atherosclerotic plaque. Annexin V could potentially deliver carried materials (such as superparamagnetic contrast agents for magnetic resonance imaging) to sites containing apoptotic cells, such as high grade atherosclerotic lesions, so we administered biochemically-derivatized (annexin V) superparmagnetic iron oxide particles (SPIONs) parenterally to two related rabbit models of human atherosclerosis. We observe development of negative magnetic resonance imaging (MRI) contrast in atheromatous lesions and but not in healthy artery. Vascular targeting by annexin V SPIONs is atheroma-specific (i.e., does not occur in healthy control rabbits) and requires active annexin V decorating the SPION surface. Targeted SPIONs produce negative contrast at doses that are 2,000-fold lower than reported for non-specific atheroma uptake of untargeted superparamagnetic nanoparticles in plaque in the same animal model. Occlusive and mural plaques are differentiable. While most of the dose accumulates in liver, spleen, kidneys and bladder, annexin V SPIONs also partition rapidly and deeply into early apoptotic foamy macrophages in plaque. Contrast in plaque decays within 2 months, allowing MRI images to be replicated with a subsequent, identical dose of annexin V SPIONs. Thus, biologically targeted superparamagnetic contrast agents can contribute to non-invasive evaluation of cardiovascular lesions by simultaneously extracting morphological and biochemical data from them.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.References
E.T. Ahrens, M. Feili-Hariri, H. Xu, G. Genove, P.A. Morel, Magn. Reson. Med. 49, 1006–1013 (2003)
A.K. Belizaire, L. Tchistiakova, Y. St-Pierre, V. Alakhov, Biochem. Biophys. Res. Commun. 309, 625–630 (2003)
V. Bhatia, R. Bhatia, S. Dhindsa, A. Virk, J. Postgrad. Med. 49, 361–368 (2003)
Y. Cui, D. Zhao, H. Liu, Z. Ning, J. Yang, X. Qing, S. Yu, C. Wu, Maturitas 50, 337–343 (2005)
J.R. Davies, J.F. Rudd, T.D. Fryer, P.L. Weissberg, J. Nucl. Cardiol. 12, 234–246 (2005)
R. Duncan, Chem. Ind. 7, 262–264 (1997a)
R. Duncan, J. Drug Target. 5, 1–4 (1997b)
R. Duncan, S. Gac-Breton, R. Keane, R. Musila, Y.N. Sat, R. Satchi, F. Searle, J. Control. Release 74, 135–146 (2001)
Y. Gavrieli, Y. Sherman, S.A. Ben-Sasson, J. Cell Biol. 119, 493–501 (1992)
D.S. Goldin, C.A. Dahl, K.L. Olsen, L.H. Ostrach, R.D. Klausner, Science 292, 443–445 (2001)
D. Hartung, M. Sarai, A. Petrov, F. Kolodgie, N. Narula, J. Verjans, R. Virmani, C. Reutelingsperger, L. Hofstra, J. Narula, J. Nucl. Med. 46, 2051–2056 (2005)
L. Hegyi, S.J. Hardwick, R.C. Siow, J.N. Skepper, J. Hematother. Stem Cell Res. 10, 27–42 (2001)
T. Ito, S. Yamada, M. Shiomi, Exp. Anim. 53, 339–346 (2004)
R.K. Jain, J. Control. Release 53, 49–67 (1998)
F.D. Kolodgie, H.K. Gold, A.P. Burke, D.R. Fowler, H.S. Kruth, D.K. Weber, A. Farb, L.J. Guerrero, M. Hayase, R. Kutys, J. Narula, A.V. Finn, R. Virmani, N. Engl. J. Med. 349, 2316–2325 (2003a)
F.D. Kolodgie, A. Petrov, R. Virmani, N. Narula, J.W. Verjans, D.K. Weber, D. Hartung, N. Steinmetz, J.L. Vanderheyden, M.A. Vannan, H.K. Gold, C.P. Reutelingsperger, L. Hofstra, J. Narula, Circulation 108, 3134–3139 (2003b)
F.D. Kolodgie, R. Virmani, A.P. Burke, A. Farb, D.K. Weber, R. Kutys, A.V. Finn, H.K. Gold, Heart 90, 1385–1391 (2004)
S.C. Lee, M. Ruegsegger, P.D. Barnes, B.R. Smith, M. Ferrari, in The Nanotechnology Handbook, ed by B. Bhushan (Springer, Heidelberg, Germany, 2004a), pp. 279–322
S.C. Lee, M. Ruegsegger, M. Ferrari, in The Encyclopedia of Nanoscience and Nanotechnology, ed. by H.S. Nalwa (American Scientific Publishers, Stevenson Ranch, CA, 2004b)
W. Li, A. Hellsten, L.S. Jacobsson, H.M. Blomqvist, A.G. Olsson, X.M. Yuan, J. Mol. Cell. Cardiol. 37, 969–978 (2004)
P. Libby, G. Sukhova, R.T. Lee, Z.S. Galis, J. Cardiovasc. Pharmacol. 25(Suppl 2), S9–12 (1995)
C. Liu, G. Bhattacharjee, W. Boisvert, R. Dilley, T. Edgington, Am. J. Pathol. 163, 1859–1871 (2003)
F. Lupu, N. Moldovan, J. Ryan, D. Stern, N. Simionescu, Blood Coagul. Fibrinolysis 4, 743–752 (1993)
H. Maeda, T. Sawa, T. Konno, J. Cont. Release 74, 47–61 (2001)
M. McAuliffe, F. Lalonde, D. McGarry, W. Gandler, K. Csaky, B. Trus, in IEEE Computer-based Medical Systems (CBMS) (2001), pp. 381–386
M. Meuwissen, A.C. van der Wal, K.T. Koch, C.M. van der Loos, S.A. Chamuleau, P. Teeling, R.J. de Winter, J.G. Tijssen, A.E. Becker, J.J. Piek, Am. J. Med. 114, 521–527 (2003)
N.I. Moldovan, L. Moldovan, N. Simionescu, Blood Coagul. Fibrinolysis 5, 921–928 (1994)
P.R. Moreno, K.R. Purushothaman, M. Sirol, A.P. Levy, V. Fuster, Circulation 113, 2245–2252 (2006)
M. Naghavi, P. Libby, E. Falk, S.W. Casscells, S. Litovsky, J. Rumberger, J.J. Badimon, C. Stefanadis, P. Moreno, G. Pasterkamp, Z. Fayad, P.H. Stone, S. Waxman, P. Raggi, M. Madjid, A. Zarrabi, A. Burke, C. Yuan, P.J. Fitzgerald, D.S. Siscovick, C.L. de Korte, M. Aikawa, K.E. Juhani Airaksinen, G. Assmann, C.R. Becker, J.H. Chesebro, A. Farb, Z.S. Galis, C. Jackson, I.K. Jang, W. Koenig, R.A. Lodder, K. March, J. Demirovic, M. Navab, S.G. Priori, M.D. Rekhter, R. Bahr, S.M. Grundy, R. Mehran, A. Colombo, E. Boerwinkle, C. Ballantyne, W. Insull Jr., R.S. Schwartz, R. Vogel, P.W. Serruys, G.K. Hansson, D.P. Faxon, S. Kaul, H. Drexler, P. Greenland, J.E. Muller, R. Virmani, P.M. Ridker, D.P. Zipes, P.K. Shah, J.T. Willerson, Circulation 108, 1664–1672 (2003)
N. Nighoghossian, L. Derex, P. Douek, Stroke 36, 2764–2772 (2005)
J. Riemer, H.H. Hoepken, H. Czerwinska, S.R. Robinson, R. Dringen, Anal. Biochem. 331, 370–375 (2004)
S.G. Ruehm, C. Corot, P. Vogt, S. Kolb, J.F. Debatin, Circulation 103, 415–422 (2001)
E.A. Schellenberger, A. Bogdanov Jr., D. Hogemann, J. Tait, R. Weissleder, L. Josephson, Mol. Imaging 1, 102–107 (2002)
M. Shiomi, T. Ito, S. Yamada, S. Kawashima, J. Fan, Arterioscler. Thromb. Vasc. Biol. 23, 1239–1244 (2003)
P.K. Smith, R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, D.C. Klenk, Anal. Biochem. 150, 76–85 (1985)
V.E. Stoneman, M.R. Bennett, Clin. Sci. (Lond) 107, 343–354 (2004)
H.W. Strauss, M. Dunphy, N. Tokita, J. Nucl. Med. 45, 1106–1107 (2004)
R. Weissleder, G. Elizondo, J. Wittenberg, C. Rabito, H. Bengele, L. Josephson, Radiology 175, 489–493 (1990a)
R. Weissleder, P. Reimer, A.S. Lee, J. Wittenberg, T.J. Brady, AJR Am J Roentgenol 155, 1161–1167 (1990b)
Acknowledgments
The authors acknowledge George Hinkle, Charles Hitchcock, Nathan Hall, Noe Tirado-Muniz, Krista LaPerle and Donna Kusewitt for their technical support and advice. This work supported was by BRTT02-0001, a grant from the Biomedical Research and Technology Transfer Commission of Ohio and National Science Foundation Grant No. 0221678.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s10544-007-9136-5
Rights and permissions
About this article
Cite this article
Smith, B.R., Heverhagen, J., Knopp, M. et al. Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI). Biomed Microdevices 9, 719–727 (2007). https://doi.org/10.1007/s10544-007-9081-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10544-007-9081-3